Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ

Figure 1

Histology of baseline (A, C, E) and endocrine-treated (B, D, F) DCIS from patient H-20 (magnification: 100×). A, B: H&E stain of baseline (A) and treated (B) samples. The treated DCIS is less distended and demonstrates increased periductal sclerosis and inflammation compared to baseline. C, D: Ki67; reduction in Ki-67 after treatment compared to baseline; E, F: CD68 (inset: 400×); increased CD68-positive macrophages after treatment compared to baseline.

Back to article page